Kesmalea Therapeutics

London, United Kingdom · Founded 2020 · Privately Held (backing)

Developer of a pipeline of therapeutics designed to transform large protein degraders into small molecules for targeted protein degradation. Kesmalea Therapeutics is based in London, United Kingdom and was founded in 2020. Its last known valuation is $39 million. It has raised $37.8 million.

Last price · $/share

—

Implied valuation

$39.0M

Total raised

$37.8M

Last round

—

How much has Kesmalea Therapeutics raised?

$37.8Macross 0 recorded rounds

Free account

More of Kesmalea Therapeutics with a free account

·Watch Kesmalea Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Kesmalea Therapeutics investors

3 investors are on record for Kesmalea Therapeutics, including Oxford Science Enterprises, BioInnovation Institute and Syncona.

For fundraisers

Raising for a company like Kesmalea Therapeutics?

3 investors have backed Kesmalea Therapeutics.

See all 3 investors →

Frequently asked about Kesmalea Therapeutics

How much has Kesmalea Therapeutics raised?: Kesmalea Therapeutics has raised $37.8M in total across 0 recorded funding rounds.